MHRA Pipeline Intelligence Webinar Recording MHRA is requesting that current or potential medicines MAHs provide information on planned or potential future submissions to MHRA. The recording of the webinar on this new forecasting process, which took place in September 2024, has been published. MHRA Pipeline Intelligence Webinar Recording
HPRA Updated Q&A on Windsor Framework – Joint Labels Between IE/UK The Health Products Regulatory Authority (HPRA) has published an updated Q&A document relating to the impact of the Windsor Framework on the regulation of human medicines. The document is based on questions HPRA has received from companies and includes updated information on joint labels between IE/UK. HPRA Updated Q&A on Windsor Framework – Joint Labels Between IE/UK
MHRA Letter on Windsor Framework Preparedness MHRA has shared a reminder of the continued preparations required ahead of the implementation of the Windsor Framework on 1 January 2025. MHRA Letter on Windsor Framework Preparedness
MHRA Performance Data for Assessment of New Marketing Authorisations, Variations and Clinical Trial Authorisation The MHRA performance metrics for new marketing authorisation applications, variations, and clinical trial authorisation assessment have been updated. MHRA Performance Data for Assessment of New Marketing Authorisations, Variations and Clinical Trial Authorisation
MHRA Marketing Authorisations Granted 15 to 30 September MHRA granted 1 OTC licence during 15-30 September 2024. MHRA Marketing Authorisations Granted 15 to 30 September
Invest 2035: The UK’s Modern Industrial Strategy The Department for Business and Trade has launched a green paper consultation on its proposals for a national long-term industrial strategy. Invest 2035: The UK’s Modern Industrial Strategy
TOPRA: CRED Prescription to Non-Prescription Medicines Switch in EU PAGB's CEO Michelle Riddalls will be presenting at a new TOPRA course ‘CRED Prescription to Non-Prescription Medicines Switch in EU’ which will take place online on 6 November between 9:15am – 5pm (GMT). TOPRA: CRED Prescription to Non-Prescription Medicines Switch in EU
MHRA Webinar – Processes to Manage Medicines Supply Disruptions MHRA is running a webinar on processes to manage medicines supply disruptions on Thursday 7 November 2024, from 11:00am – 12:30pm (GMT). MHRA Webinar – Processes to Manage Medicines Supply Disruptions
AESGP Webinar – The Impact of the Revised CLP Regulation on the Self-care Sector AESGP is hosting a webinar on the impact of the revised classification, labelling and packaging (CLP) regulation on the self-care sector, in collaboration with Fieldfisher, on Tuesday 12 November. AESGP Webinar – The Impact of the Revised CLP Regulation on the Self-care Sector
MHRA Guidance Updates MHRA has updated some of its guidance pages primarily to add details of changes with respect to the Windsor Framework and to update contact information. MHRA Guidance Updates
MHRA Webinar – Reclassification Process for Medicines in the UK MHRA is running a webinar on the reclassification process for medicines in the UK on Tuesday 12 November from 10am – 11:30am (GMT). MHRA Webinar – Reclassification Process for Medicines in the UK
eLearning with PAGB: New UK Medicines Regulation Course We have launched our new training platform, eLearning with PAGB, with new suite of on-demand training courses and free webinars. eLearning with PAGB: New UK Medicines Regulation Course
